Recently, AKT was found to be overactivated in high-risk CLL and in more than 50% of CLL patients having Richter’s transformation (RT), a highly aggressive form of lymphoma that is developed by 2 – 10% of patients during the clinical progression of CLL (108). This evidence concerns the gene AKT1 and B-cell chronic lymphocytic leukemia.